Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Chance Orders of Alternating Stimuli in Visual Discrimination Experiments
Gellermann, L. W. (1933) · The Pedagogical Seminary and Journal of Genetic Psychology · doi:10.1080/08856559.1933.10534237 · Cited by 1,178
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
Fischer, W., Wictorin, K., Björklund, A., Williams, L. R., Varon, S., & Gage, F. H. (1987) · Nature · doi:10.1038/329065a0 · Cited by 1,024
A mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913
Gnahn, H., Hefti, F., Heumann, R., Schwab, M. E., & Thoenen, H. (1983) · Developmental Brain Research · doi:10.1016/0165-3806(83)90107-4 · Cited by 719
Seiler, M., & Schwab, M. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)91338-6 · Cited by 591
Pittler, S. J., & Baehr, W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8322 · Cited by 564
Milward, E. A., Papadopoulos, R., Fuller, S. J., Moir, R. D., Small, D., Beyreuther, K., & Masters, C. L. (1992) · Neuron · doi:10.1016/0896-6273(92)90228-6 · Cited by 458
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448
Cited by
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
The neuropsychology of down syndrome: evidence for hippocampal dysfunction.
Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003) · Child Development · doi:10.1111/1467-8624.00522 · Cited by 514
Nixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400
“NGF trophic support to BFCNs is thus disrupted, which induces atrophy of these neurons and cholinergic deficits inDSmousemodels (21, 92) that can be rescued by raising NGF levels (93).”
BackgroundThe history of the cholinergic hypothesis
Contestabile, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.044 · Cited by 374
Assessment of spatial memory in mice
Sharma, S., Rakoczy, S., & Brown-Borg, H. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.09.004 · Cited by 368
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336
Nurturing brain plasticity: Impact of environmental enrichment
Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Sale, A., & Maffei, L. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.193 · Cited by 330
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 299
Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297
“…neurons of the medial septum, which project to the hippocampus, show progressive age-related degenerative changes (Holtzman et al., 1996; Granholm et al., 2000; Cooper et al., 2001), a finding that recapitulates the degeneration of these neurons in DS and in AD (Whitehouse et al., 1982;…”
BackgroundDown syndrome and Alzheimer's disease: common pathways, common goals
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290
Self-citationDown syndrome--recent progress and future prospects
Wiseman, F. K., Alford, K. A., Tybulewicz, V. L. J., & Fisher, E. M. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp010 · Cited by 248
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
Bianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., Fernandez, M., Giuliani, A., Calza, L., & Bartesaghi, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0534-10.2010 · Cited by 188
“The serotonergic, noradrenergic, GABAergic, and cholinergic systems are altered in trisomic mice and DS fetuses (Bar-Peled et al., 1991; Fiedler et al., 1994; Dierssen et al., 1997; Granholm et al., 2000; Kleschevnikov et al., 2004; Whittle et al., 2007) and although these alterations might be involved in neurogenesis…”
BackgroundCosta, A. C. S., & Grybko, M. J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.031 · Cited by 174
Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171
Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134
“BFCN degeneration occurs from 6–10 months of age up to 20 months of age (Granholm et al., 2000; Holtzman et al., 1996; Hunter et al., 2004a; Lockrow et al., 2009).”
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131
Ayberk Kurt, M., Ilker Kafa, M., Dierssen, M., & Ceri Davies, D. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.075 · Cited by 126
Hyde, L. A., Frisone, D. F., & Crnic, L. S. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00313-2 · Cited by 108
Self-citationGarcía-Cerro, S., Rueda, N., Vidal, V., Lantigua, S., & Martínez-Cué, C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.010 · Cited by 100
Jiang, Y., Rigoglioso, A., Peterhoff, C. M., Pawlik, M., Sato, Y., Bleiwas, C., Stavrides, P., Smiley, J. F., Ginsberg, S. D., Mathews, P. M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.013 · Cited by 97
Choi, J. H. K., Berger, J. D., Mazzella, M. J., Morales‐Corraliza, J., Cataldo, A. M., Nixon, R. A., Ginsberg, S. D., Levy, E., & Mathews, P. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06277.x · Cited by 83
“Because the Ts65Dn mouse has age-related decreased cognitive ability (Reeves et al. 1995; Demas et al. 1996, 1998; Holtzman et al. 1996; Hunter et al. 2003a) and Appgene dosage-dependent loss of vulnerable BFCNs (Granholm et al. 2000; Cooper et al. 2001), it is a good model system to examine in vivo the potential inte…”
BackgroundInfluentialAtas-Ozcan, H., Brault, V., Duchon, A., & Herault, Y. (2021) · Genes · doi:10.3390/genes12111833 · Cited by 78
Kaur, G., Sharma, A., Xu, W., Gerum, S., Alldred, M. J., Subbanna, S., Basavarajappa, B. S., Pawlik, M., Ohno, M., Ginsberg, S. D., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5338-13.2014 · Cited by 58
“Furthermore, it was demonstrated that selective GABA and NMDA receptor antagonists can reverse functional and neuromorphological deficits of Ts65Dn mice by facilitating brain plasticity, supporting the potential therapeutic use of these selective antagonists to treat cognitive dys- function in DS (Boada et al., 2012;…”
MethodInfluentialPredictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia
Brigman, J. L. (2010) · Frontiers in Neuroscience · doi:10.3389/neuro.01.013.2010 · Cited by 52
“…and Eleftheriou (1972) Spatial APP/PS1 transgenic Age-related impairment Filali and Lalonde (2009) Spatial Ts65Dn cholinergic defi cient Down’s model Impaired Granholm et al. (2000) Spatial DARPP-32 knockout Impaired Heyser et al. (2000) Spatial PEPCK bGH transgenic elevated growth hormone…”
BackgroundCognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
D. Hamlett, E., A. Boger, H., Ledreux, A., M. Kelley, C., J. Mufson, E., F. Falangola, M., N. Guilfoyle, D., A. Nixon, R., Patterson, D., Duval, N., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921095505 · Cited by 46
Brain circuit pathology in Down syndrome: from neurons to neural networks
Bartesaghi, R. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0067 · Cited by 25
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, C., Mumford, P., & Wiseman, F. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909669 · Cited by 22
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Reduced cortical neurotransmitter receptor complex levels in fetal Down syndrome brain
Keihan Falsafi, S., Dierssen, M., Ghafari, M., Pollak, A., & Lubec, G. (2016) · Amino Acids · doi:10.1007/s00726-015-2062-6 · Cited by 13
Metadata
- Authors
- Granholm, A.-C. E., Sanders, L. A., & Crnic, L. S.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2000-02
- Volume
- 161
- Issue
- 2
- Pages
- 647-663
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2094489923
- Cited by
- 228
- References
- 70
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.